Skip to content

Clinical trials

Completed Idiopathic Pulmonary Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Completed Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20121
20133
20151
20162
20191
20204
20212
20224
20233
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Bristol-Myers Squibb2
Endeavor Biomedicines, Inc.2
Actelion1
Algernon Pharmaceuticals1
Bridge Biotherapeutics, Inc.1
CSL Behring1
GRI Bio Operations, Inc.1
Galecto Biotech AB1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis28
Pulmonary Fibrosis5
Lung Diseases, Interstitial3
Cough2
Idiopathic Interstitial Pneumonias2
Bronchiectasis1
Cystic Fibrosis1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.